One Health Group PLC - Director/PDMR Shareholding

Announcement provided by

One Health Group PLC · OHGR

31/03/2023 08:20

RNS Number : 9187U

One Health Group PLC

31 March 2023

One Health Group PLC

PDMR Share Dealing

TR1 - Notification of Major Holdings

31 March 2023

One Health Group PLC ("One Health" or the "Company") announces that Shantanu Shahane, a director and person discharging managerial responsibilities in the Company, purchased 60,000 ordinary shares of 0.5 pence each in the capital of the Company ("Ordinary Shares") following the exercise of options granted under the One Health Group Share Option Plan ("Share Options").

Further details of the disclosure made to the Company by Shantanu Shahane are contained in Appendix 1.

Following the above dealing, Shantanu Shahane is, directly or indirectly, beneficially interested in 350,000 Ordinary Shares representing 3.33% of the issued share capital of the Company.

Appendix 2 contains a disclosure form relating to Shantanu Shahane who has notified One Health that he controls over 3% of the Total Voting Rights in the Company as a result of his acquisition of Ordinary Shares outlined above.

Following the exercise of the Share Options, Derek Bickerstaff, a director and Chair of One Health and who controls over 3% of the Total Voting Rights in the Company, has notified One Health that his percentage interest in Ordinary Shares has reduced to approximately 57.09% of the issued share capital of the Company. Derek Bickerstaff did not acquire Ordinary Shares as a result of the exercise of the Share Options. Further details are contained in the disclosure form in Appendix 3.

This announcement contains inside information for the purposes of Article 7 of EU Regulation
596/2014. Which is part of the United Kingdom domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)("UK MAR").

The directors of One Health accept responsibility for this announcement.

Enquiries

One Health Group plc

Via Square 1 Consulting

Oberon Capital (AQSE Corporate Adviser and Broker)

Nick Lovering, Mike Seabrook

020 3179 5300

Square 1 Consulting

David Bick

020 7929 5599

Appendix 1

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.		Details of the person discharging managerial responsibilities/person closely associated

a)					Name:			Shantanu Shahane

2.						Reason for the notification

a)			Position/status:						Medical Director
b			Initial notification/Amendment:						Initial notification

3.		Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)				Name:			One Health Group plc
b)				LEI:			984500DC689F5BAD8732
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)	Description of the financial instrument, type of instrument: Identification code:	Ordinary shares of £0.005 each ISIN Code: GB00BNNT0595
b)	Nature of the transaction:	Purchase of share pursuant to the exercise of options
c)	Price(s) and Volume (s):	Purchase price(s). 66.7p per share Volume(s): 60,000
d)	Aggregated Information: Aggregated volume: Price:	60,000 £40,200
e)	Date of the transaction:	30 March 2023
f)	Place of the transaction	Aquis (AQSE)

Appendix 2

Disclosure forms re major share holdings

TR-1: standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) ⁱ

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ⁱⁱ:			ONE HEALTH GROUP PLC 131 Psalter Lane Sheffield S11 8UX LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) ⁱⁱⁱ:
3. Details of person subject to the notification obligation ^iv
Name			Shantanu Shahane
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.) ^v
Name			As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached ^vi:			30^th March 2023
6. Date on which issuer notified (DD/MM/YYYY):			30^th March 2023
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) ^vii
Resulting situation on the date on which threshold was crossed or reached	3.33%			3.33%	350,000
Position of previous notification (if applicable)	N/A			N/A

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached ^viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ^ix					% of voting rights
		Direct (DTR5.1)		Indirect (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB00BNNT0595		60,000		290,000			0.57%		2.76%


SUBTOTAL 8. A		350,000					3.33%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date ^x	Exercise/ Conversion Period ^xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights



			SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date ^x		Exercise/ Conversion Period ^xi		Physical or cash Settlement ^xii			Number of voting rights	% of voting rights



					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer ^xiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) ^xiv				x
Name ^xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Shantanu Shahane	0.57%		0.57%
Shahane Consultancy Ltd	2.76%		2.76%




10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information ^xvi

Place of completion	Aquis (AQSE)
Date of completion	30^th March 2023

Appendix 3

TR-1: standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ⁱⁱ:			ONE HEALTH GROUP PLC 131 Psalter Lane Sheffield S11 8UX LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights						X
Other (please specify) ⁱⁱⁱ:
3. Details of person subject to the notification obligation ^iv
Name			Derek Richard Bickerstaff
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.) ^v
Name			As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached ^vi:			30^th March 2023
6. Date on which issuer notified (DD/MM/YYYY):			30^th March 2023
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) ^vii
Resulting situation on the date on which threshold was crossed or reached	57.09%			57.09%	6,000,000
Position of previous notification (if applicable)	59.8%			59.8%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached ^viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ^ix					% of voting rights
		Direct (DTR5.1)		Indirect (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB00BNNT0595		6,000,000					57.09%


SUBTOTAL 8. A		6,000,000					57.09%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date ^x	Exercise/ Conversion Period ^xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights



			SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date ^x		Exercise/ Conversion Period ^xi		Physical or cash Settlement ^xii			Number of voting rights	% of voting rights



					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer ^xiii				x
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) ^xiv
Name ^xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold






10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information ^xvi

Place of completion	Aquis (AQSE)
Date of completion	30^th March 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGRGDXBBXDGXB ]]>

OHGR announcements All announcements